Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren’s syndrome
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07190-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Xiaoyu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Southwest Hospital, Army Medical University (the Third Military Medical University), Chongqing, 400038, Pe…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Autoantibodies, Biomarkers, Aquaporin 5. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Chongqing Science and Health Joint Traditional Chinese Medicine Technology Key Project, Chongqing Traditional Chinese Medicine Research Project.
Abstract (Originalsprache)
The study aims to assess the diagnostic and clinical significance of autoantibodies against aquaporin-1 (anti-AQP1) and aquaporin-5 (anti-AQP5) in primary Sjögren’s syndrome (pSS). A total of 163 participants were categorized into three groups: pSS group, other connective tissue diseases (CTD) group, and healthy control (HC) group. The levels of anti-AQP1 and anti-AQP5 autoantibodies in serum were determined using enzyme-linked immunosorbent assay (ELISA), and clinical data from patients were collected for statistical analysis. Our results showed that the level of anti-AQP1 in the pSS group was higher than in the HC group ( P < 0.05), and no significant difference was observed between the pSS group and the CTD group ( P > 0.05). ROC showed that the anti-AQP1 had no diagnostic value for pSS ( P > 0.05). The anti-AQP5 level of 39 healthy adults was all below the cut-off value (14.10 ng/ml) ( P < 0.05). The level of anti-AQP5 in the pSS group was higher than the CTD group ( P < 0.05), the AUC was 0.86 (95% CI 0.80–0.93), with a sensitivity of 0.95 (95% CI 0.87–0.99) and a specificity of 0.70 (95% CI 0.58–0.84). No correlation was found between anti-AQP5 levels and the EULAR primary Sjögren’s syndrome disease activity index score, anti-SSA, anti-SSB, antinuclear antibodies, rheumatoid factor, anti-ds-DNA, salivary gland flow rate, complement 3, and lymphocyte count in pSS samples ( P > 0.05), respectively. Therefore, the elevated anti-AQP5 may emerge as a novel diagnostic biomarker for pSS patients due to high sensitivity and specificity. Key Points • The elevated anti-AQP5 may emerge as a novel diagnostic biomarker for pSS patients due to high sensitivity and specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Southwest Hospital, Army Medical University (the Third Military Medical University), Chongqing, 400038, People's Republic of China.
- Department of Clinical Laboratory, Southwest Hospital, Army Medical University (the Third Military Medical University), Chongqing, 400038, People's Republic of China.
- Department of Rheumatology and Immunology, Southwest Hospital, Army Medical University (the Third Military Medical University), Chongqing, 400038, People's Republic of China. wangyongjhy@tmmu.edu.cn.
Förderung
- the Chongqing Science and Health Joint Traditional Chinese Medicine Technology Key Project
- Chongqing Traditional Chinese Medicine Research Project
Zitieren
APA
Wang, X., Wu, H., Zhong, B., Zhang, L., & Wang, Y. (2024). Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren’s syndrome. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07190-1
Vancouver
Wang X, Wu H, Zhong B, Zhang L, Wang Y. Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren’s syndrome. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07190-1
BibTeX
@article{Wang2024,
author = {Wang, Xiaoyu and Wu, Hong and Zhong, Bing and Zhang, Ligai and Wang, Yong},
title = {Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren’s syndrome},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07190-1}
}
EUVIMED